We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Marshals Seize Unapproved Drug From Crescendo Therapeutics
U.S. Marshals Seize Unapproved Drug From Crescendo Therapeutics
June 4, 2012
After a warning letter and two failed inspections, the FDA called in the big guns, requesting that U.S. marshals seize an unapproved, misbranded scar removal drug marketed by Crescendo Therapeutics.